Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Mediated”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05156710
What this trial is testing

BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)

Who this might be right for
Transplant Rejection
Sanofi 48
Large-scale testing (Phase 3)Enrolling By InvitationNCT07444489
What this trial is testing

Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE)

Who this might be right for
Antibody-mediated RejectionMicrovascular Inflammation
Biogen 201
Early research (Phase 1)Looking for participantsNCT06308978
What this trial is testing

FT819 in B-cell Mediated Autoimmune Disease

Who this might be right for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more
Fate Therapeutics 244
Large-scale testing (Phase 3)Study completedNCT00892112
What this trial is testing

Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy

Who this might be right for
Myocardial DiseasesParvovirus B19, Human
Prothya Biosolutions 50
Not applicableEnded earlyNCT02133248
What this trial is testing

Identification of Donor Specific B Cells and Antibody Mediated Rejection

Who this might be right for
Sensitized Kidney Transplant Recipients
University of Wisconsin, Madison 86
Not applicableStudy completedNCT03719339
What this trial is testing

VIRTUUS Children's Study

Who this might be right for
Renal Transplant RejectionPediatric Kidney DiseaseEnd Stage Renal Disease+4 more
Children's Hospital of Philadelphia 445
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Testing effectiveness (Phase 2)Looking for participantsNCT06733935
What this trial is testing

NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Who this might be right for
Systemic SclerosisIdiopathic Inflammatory MyopathiesAntineutrophil Cytoplasmic Antibody-Associated Vasculitis+1 more
Nkarta, Inc. 240
Testing effectiveness (Phase 2)Ended earlyNCT01895127
What this trial is testing

Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation

Who this might be right for
Antibody-mediated RejectionHumoral Rejection
Brigham and Women's Hospital 11
Not applicableAvailableNCT06631677
What this trial is testing

Expanded Access of Dupilumab in Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy Previously Treated With Linvoseltamab

Who this might be right for
Food Allergy
Regeneron Pharmaceuticals
Not applicableStudy completedNCT05089565
What this trial is testing

Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis

Who this might be right for
SarcoidosisSARS-CoV2 InfectionVaccine Response Impaired
Northwestern University 101
Not applicableStudy completedNCT03737136
What this trial is testing

Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

Who this might be right for
Antibody-mediated Rejection
Shahid Beheshti University of Medical Sciences 20
Not applicableStudy completedNCT03393793
What this trial is testing

HEart trAnsplantation Registry of piTie-Salpetriere University Hospital

Who this might be right for
Cardiac Transplant DisorderCardiac DeathHeart Failure+5 more
Lee S Nguyen 566
Early research (Phase 1)Study completedNCT03319459
What this trial is testing

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

Who this might be right for
HER2 Positive Gastric CancerColorectal CancerHead and Neck Squamous Cell Carcinoma+8 more
Fate Therapeutics 44
Early research (Phase 1)Study completedNCT05004259
What this trial is testing

The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia

Who this might be right for
Hemolytic Anemia
Dartmouth-Hitchcock Medical Center 2
Not applicableLooking for participantsNCT06968442
What this trial is testing

The Role of Obesity in Severe COVID-19 Pathophysiology

Who this might be right for
COVID-19Antibody COVID-19
Franciscus Gasthuis 60
Testing effectiveness (Phase 2)Study completedNCT03897205
What this trial is testing

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Who this might be right for
Kidney Transplant Rejection
Hansa Biopharma AB 30
Testing effectiveness (Phase 2)Study completedNCT00771875
What this trial is testing

Randomized Trial for Mixed Acute Rejection

Who this might be right for
Graft Rejection
University of Cincinnati 30
Testing effectiveness (Phase 2)Study completedNCT04626505
What this trial is testing

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.

Who this might be right for
Chronic Kidney DiseaseInflammationCardiovascular Risk
Novo Nordisk A/S 36
Next Page